Work

Targeted therapy for non-small cell lung cancer (NSCLC) with HER2, BRAF, or hedgehog alterations: Interim data from MyPathway.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.9073

Authors: John D. Hainsworth, Ron Bose, Christopher Sweeney, Funda Meric-Bernstam, Herbert Hurwitz, Charles Swanton, Howard A. Burris, Razelle Kurzrock, Bongin Yoo, Mary Stanley Beattie, Ravindra Gupta, Rajesh D. Patel, Katja Schulze, David R. Spigel

Institutions: Tennessee Oncology, Washington University in St. Louis, Harvard University, Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center, Duke Medical Center, The Francis Crick Institute, University of California San Diego, Moores Cancer Center, Genentech

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891160279

Cites:

Cited by: 6

Related to: 10